2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

J Thorac Cardiovasc Surg. 2014 Jul;148(1):e1-e132. doi: 10.1016/j.jtcvs.2014.05.014. Epub 2014 May 9.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Aortic Valve Insufficiency / diagnosis
  • Aortic Valve Insufficiency / therapy
  • Aortic Valve Stenosis / diagnosis
  • Aortic Valve Stenosis / therapy
  • Cardiac Catheterization*
  • Cardiology / standards*
  • Cardiovascular Agents / therapeutic use*
  • Disease Management
  • Echocardiography
  • Evidence-Based Medicine / standards
  • Exercise Test* / adverse effects
  • Exercise Test* / methods
  • Heart Defects, Congenital / complications
  • Heart Valve Diseases / complications
  • Heart Valve Diseases / diagnosis*
  • Heart Valve Diseases / etiology
  • Heart Valve Diseases / physiopathology
  • Heart Valve Diseases / therapy*
  • Heart Valve Prosthesis Implantation* / standards
  • Hemodynamics
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Mitral Valve Insufficiency / diagnosis
  • Mitral Valve Insufficiency / therapy
  • Mitral Valve Stenosis / diagnosis
  • Mitral Valve Stenosis / therapy
  • Patient Care Team
  • Pharyngitis / complications
  • Pharyngitis / microbiology
  • Referral and Consultation
  • Rheumatic Fever / etiology
  • Rheumatic Fever / prevention & control*
  • Secondary Prevention / methods
  • Severity of Illness Index
  • Streptococcal Infections / complications
  • United States
  • Vasodilator Agents / therapeutic use
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / therapy

Substances

  • Antihypertensive Agents
  • Cardiovascular Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Vasodilator Agents